| Previous Close | Open | Close* |
|---|---|---|
| 0.13 | 0.13 | 0.125 |
| Market Cap | Dividend Yield (Annualized) |
|---|---|
| AUD 22.129M | 0.00% |
| Day Range |
|---|
| 0.125L 0.13 H |
| 52 WEEK HIGH LOW |
|---|
| 0.11L 0.35 H |
| Last Trade | 0.125 |
|---|---|
| Change% | -3.8462 |
| 52 W H/L | 0.350/0.110 |
| EBITDA | -2.538M |
| NPAT After Abnormal Items | -2.396M |
| Equity | 4.246M |
| ROE% | -56.43% |
| Total Liabilities | 754,573 |
| Total Revenue | 604,085 |
| Cash and Cash Equivalents | 3.933M |
| Share price | 0.125 |
|---|---|
| Market Cap | 22.129M |
| Price/Gross Cash Flow | -15.83 |
| Dividend Yield Excluding Special | 0.00% |
| Ending Shares | 153.633M |
| 52-Week Range | 0.350-0.110 |
| Gross DPS (AUD) | 0 |
| Gross Dividend Yield (Annualized) | 0.00% |
| Earnings Yield | 0.000 |
| Net Tangible Asset (NTA) | 0.03 |
| P/E ratio | 0.000 |
| Sector P/E | -- |
| EPS | -1.75 |
| EV/EBITDA | -- |
| Net Profit Margin (%) | -418.11% |
| Gross Cash Flows Per Share | -0.01 |
| Net Gearing | -92.63% |
| Sales Per Share | 0.00 |
| Book Value Per Share | 0.03 |
Bio-Gene Technology Limited (ASX: BGT), incorporated in 1995, is a biotechnology company in Australia that is engaged in the development of insecticides. It first discovered the insecticidal activity of ?-triketone chemical class followed by a botanical screening program. It aims at identifying natural product-based insecticides in Australian flora. It is into the development of two products: Qcide and Flavocide.
Level 6, 400 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
| Ex-Date | Net Dividend | Frank Flag | Period End Date | Type | Payable |
|---|
| Event Type | Event Date | Event Year |
|---|---|---|
| Report (Interim) | 2023-02-16 | 2023 |
| Report (Annual) | 2022-08-25 | 2022 |
| Report (Prelim) | 2022-08-25 | 2022 |